Literature DB >> 11337311

Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue: acute and chronic effects in an animal model.

J D Crowley1, J Shelton, A J Iverson, M P Burton, N C Dalrymple, J T Bishoff.   

Abstract

OBJECTIVES: To evaluate the laparoscopic and percutaneous delivery of impedance-based radiofrequency ablation (RFA) of the kidney by studying the acute and chronic clinical, radiographic, and histopathologic effects in the porcine model.
METHODS: Eight kidneys from 4 pigs underwent laparoscopic RFA. Six kidneys from 3 additional pigs received computed tomography (CT)-guided, percutaneous RFA. CT scans were performed immediately after RFA and before harvest at 2 hours, 24 hours, 3 weeks, and 13 weeks. The gross, radiographic, and histopathologic changes were recorded for each period.
RESULTS: Grossly, the RFA lesions were sharply demarcated, measuring 3 to 5 cm. Two major complications (14%) occurred (one urinoma, one psoas muscle injury) in 14 ablations. No deaths or significant blood loss occurred as a result of RFA. Radiographically, the immediate CT scanning demonstrated small perinephric hematomas and wedge-shaped defects. Delayed CT showed nonenhancing defects up to 5 cm. Color-flow and power Doppler were unable to distinguish significant tissue changes during RFA. The histopathologic evaluation revealed marked inflammation surrounding the necrotic regions in the early lesions; chronic lesions were characterized by dense fibrosis. The tissue temperatures ranged from 62 degrees to 118 degrees C in the area of ablation.
CONCLUSIONS: RFA is readily delivered laparoscopically or percutaneously with minimal morbidity. Impedance-based application of radiofrequency energy allows monitoring and control of ablation. Using a multi-antenna probe, areas of tissue up to 5 cm can be completely destroyed. The RFA lesion can be monitored as a nonenhancing cortical defect on CT.

Entities:  

Mesh:

Year:  2001        PMID: 11337311     DOI: 10.1016/s0090-4295(00)01129-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  19 in total

Review 1.  Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy.

Authors:  Nelson Salas; Rajan Ramanathan; Scott Dummett; Raymond J Leveillee
Journal:  World J Urol       Date:  2010-05-09       Impact factor: 4.226

Review 2.  Image-guided radiofrequency ablation of renal cell carcinoma.

Authors:  Andreas Boss; Stephan Clasen; Markus Kuczyk; Fritz Schick; Philippe L Pereira
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

Review 3.  Percutaneous ablation in the kidney.

Authors:  Aradhana M Venkatesan; Bradford J Wood; Debra A Gervais
Journal:  Radiology       Date:  2011-11       Impact factor: 11.105

4.  Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients.

Authors:  Andrea Veltri; Giuseppina De Fazio; Valeria Malfitana; Giuseppe Isolato; Dario Fontana; Alessandro Tizzani; Giovanni Gandini
Journal:  Eur Radiol       Date:  2004-07-27       Impact factor: 5.315

5.  Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma.

Authors:  Kent Perry; Amnon Zisman; Allan J Pantuck; Nicolette Janzen; Peter Schulam; Arie S Belldegrun
Journal:  Rev Urol       Date:  2002

6.  Selecting treatment for high-risk, localized prostate cancer: the case for radiation therapy.

Authors:  Robert Meier; Michael K Brawer
Journal:  Rev Urol       Date:  2002

Review 7.  Percutaneous radiofrequency ablation of renal cell carcinoma.

Authors:  Debra A Gervais; Ronald S Arellano; Peter R Mueller
Journal:  Eur Radiol       Date:  2005-03-09       Impact factor: 5.315

8.  Radio frequency ablation of small renal tumors:: intermediate results.

Authors:  J J Hwang; M M Walther; S E Pautler; J A Coleman; J Hvizda; James Peterson; W M Linehan; B J Wood
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

9.  Hepatic radiofrequency under CT-fluoroscopy guidance.

Authors:  D Laganà; G Carrafiello; M Mangini; D Lumia; L Mocciardini; C Chini; G Pinotti; S Cuffari; C Fugazzola
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

Review 10.  Radiofrequency ablation of renal tumors.

Authors:  Andreas H Mahnken; Rolf W Günther; Josef Tacke
Journal:  Eur Radiol       Date:  2004-05-19       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.